Literature DB >> 17218568

Evaluation of expiratory volume, diffusion capacity, and exercise tolerance following major lung resection: a prospective follow-up analysis.

Alessandro Brunelli1, Francesco Xiumé, Majed Refai, Michele Salati, Rita Marasco, Valeria Sciarra, Armando Sabbatini.   

Abstract

BACKGROUND: Lung resections determine a variable functional reduction depending on the extent of the resection and the time elapsed from the operation. The objectives of this study were to prospectively investigate the postoperative changes in FEV(1), carbon monoxide lung diffusion capacity (Dlco), and exercise tolerance after major lung resection at repeated evaluation times.
METHODS: FEV(1), Dlco, and peak oxygen consumption (Vo(2)peak) calculated using the stair climbing test were measured in 200 patients preoperatively, at discharge, and 1 month and 3 months after lobectomy or pneumonectomy. Preoperative and repeated postoperative measures were compared, and a time-series, cross-sectional regression analysis was performed to identify factors associated with postoperative Vo(2)peak.
RESULTS: One month after lobectomy, FEV(1), Dlco, and Vo(2)peak values were 79.5%, 81.5%, and 96% of preoperative values and recovered up to 84%, 88.5%, and 97% after 3 months, respectively. One month after pneumonectomy, FEV(1) percentage of predicted, Dlco percentage of predicted, and Vo(2)peak values were 65%, 75%, and 87% of preoperative values, and were 66%, 80%, and 89% after 3 months, respectively. Three months after lobectomy, 27% of patients with COPD had improved FEV(1), 34% had improved Dlco, and 43% had improved Vo(2)peak compared to preoperative values. The time-series, cross-sectional regression analysis showed that postoperative Vo(2)peak values were directly associated with preoperative values of Vo(2)peak, and postoperative values of FEV(1) and Dlco, and were inversely associated with age and body mass index.
CONCLUSIONS: Our findings may be used during preoperative counseling and for deciding eligibility for operation along with other more traditional measures of outcome.

Entities:  

Mesh:

Year:  2007        PMID: 17218568     DOI: 10.1378/chest.06-1345

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  31 in total

1.  Exercise capacity and cancer-specific quality of life following curative intent treatment of stage I-IIIA lung cancer.

Authors:  Duc Ha; Andrew L Ries; Peter J Mazzone; Scott M Lippman; Mark M Fuster
Journal:  Support Care Cancer       Date:  2018-02-10       Impact factor: 3.603

Review 2.  Preoperative functional workup for patients with advanced lung cancer.

Authors:  Alessandro Brunelli
Journal:  J Thorac Dis       Date:  2016-11       Impact factor: 2.895

Review 3.  The Utility of Exercise Testing in Patients with Lung Cancer.

Authors:  Duc Ha; Peter J Mazzone; Andrew L Ries; Atul Malhotra; Mark Fuster
Journal:  J Thorac Oncol       Date:  2016-05-05       Impact factor: 15.609

4.  Physical function and health-related quality of life in the convalescent phase in surgically treated patients with malignant pleural mesothelioma.

Authors:  Takashi Tanaka; Shinichiro Morishita; Masaki Hashimoto; Toru Nakamichi; Yuki Uchiyama; Seiki Hasegawa; Kazuhisa Domen
Journal:  Support Care Cancer       Date:  2019-02-20       Impact factor: 3.603

Review 5.  Cardiovascular Disease in Adult Cancer Survivors: a Review of Current Evidence, Strategies for Prevention and Management, and Future Directions for Cardio-oncology.

Authors:  Jaidyn Muhandiramge; John R Zalcberg; G J van Londen; Erica T Warner; Prudence R Carr; Andrew Haydon; Suzanne G Orchard
Journal:  Curr Oncol Rep       Date:  2022-07-07       Impact factor: 5.075

6.  Pulmonary function and exercise capacity in children following lung resection surgery.

Authors:  Suchada Sritippayawan; Suthinee Treerojanapon; Sompol Sanguanrungsirikul; Jitladda Deerojanawong; Nuanchan Prapphal
Journal:  Pediatr Surg Int       Date:  2012-10-18       Impact factor: 1.827

Review 7.  Long-term pulmonary function after major lung resection.

Authors:  Kazuhiro Ueda; Masataro Hayashi; Nobuyuki Tanaka; Toshiki Tanaka; Kimikazu Hamano
Journal:  Gen Thorac Cardiovasc Surg       Date:  2013-11-23

8.  A Model-Based Cost-Effectiveness Analysis of an Exercise Program for Lung Cancer Survivors After Curative-Intent Treatment.

Authors:  Duc Ha; Jacqueline Kerr; Andrew L Ries; Mark M Fuster; Scott M Lippman; James D Murphy
Journal:  Am J Phys Med Rehabil       Date:  2020-03       Impact factor: 3.412

9.  Measured versus predicted postoperative pulmonary function at repeated times up to 1 year after lobectomy.

Authors:  Takamasa Shibazaki; Shohei Mori; Eriko Harada; Rintaro Shigemori; Daiki Kato; Hideki Matsudaira; Jun Hirano; Takashi Ohtsuka
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-10-29

Review 10.  Functional capacity, physical activity and muscle strength assessment of individuals with non-small cell lung cancer: a systematic review of instruments and their measurement properties.

Authors:  Catherine L Granger; Christine F McDonald; Selina M Parry; Cristino C Oliveira; Linda Denehy
Journal:  BMC Cancer       Date:  2013-03-20       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.